Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations
Targeted Oncology · 21.11.2026
DOI: 10.1007/s11523-026-01275-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targeted Oncology, online erschienen am 21.11.2026. Verfasst von Chia-Hsin Liu und 3 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Science and Technology Council, Tri-Service General Hospital, Medical Affairs Bureau.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Science and Technology Council
- Tri-Service General Hospital
- Medical Affairs Bureau
Zitieren
APA
Liu, C., Liu, C., Liu, N., & Lin, Y. (2026). Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations. Targeted Oncology. https://doi.org/10.1007/s11523-026-01275-4
Vancouver
Liu C, Liu C, Liu N, Lin Y. Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations. Targeted Oncology. 2026. doi:10.1007/s11523-026-01275-4
BibTeX
@article{Liu2026,
author = {Liu, Chia-Hsin and Liu, Cheng-Yin and Liu, Nien-Tzu and Lin, Yu-Chun},
title = {Prognostic Significance of Immune-Cell PD-L1 Expression in Tumor Proportion Score-Negative Metastatic Non-small Cell Lung Cancer Without Documented Targetable Driver Alterations},
journal = {Targeted Oncology},
year = {2026},
doi = {10.1007/s11523-026-01275-4}
}
EUVIMED